mAbs targeting PAR-1 (Crystal Bioscience)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamemAbs targeting PAR-1 (Crystal Bioscience)
Drug Alias NamemAbs targeting protease-activated receptor-1 (Crystal Bioscience)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionProtease-activated receptor-1 modulators
TargetsProtease-activated receptor-1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCrystal Bioscience Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCrystal Bioscience Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A